<?xml version="1.0" encoding="UTF-8"?>
<ref id="B129-pharmaceuticals-13-00096">
 <label>129.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Deshotels</surname>
    <given-names>M.R.</given-names>
   </name>
   <name>
    <surname>Xia</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Sriramula</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Lazartigues</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Filipeanu</surname>
    <given-names>C.M.</given-names>
   </name>
  </person-group>
  <article-title>Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptorâ€“dependent mechanism</article-title>
  <source>Hypertension</source>
  <year>2014</year>
  <volume>64</volume>
  <fpage>1368</fpage>
  <lpage>1375</lpage>
  <pub-id pub-id-type="doi">10.1161/HYPERTENSIONAHA.114.03743</pub-id>
  <pub-id pub-id-type="pmid">25225202</pub-id>
 </element-citation>
</ref>
